A Clinical Trial to Determine the Effects of COL-101 [doxycycline hyclate] Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea

Trial Profile

A Clinical Trial to Determine the Effects of COL-101 [doxycycline hyclate] Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2008

At a glance

  • Drugs Doxycycline; Doxycycline hyclate
  • Indications Bacterial infections; Rosacea
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors CollaGenex Pharmaceuticals
  • Most Recent Events

    • 04 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top